These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2219573)

  • 21. Sexual behaviour, history of sexually transmitted diseases, and the risk of prostate cancer: a case-control study in Cuba.
    Fernández L; Galán Y; Jiménez R; Gutiérrez A; Guerra M; Pereda C; Alonso C; Riboli E; Agudo A; González C
    Int J Epidemiol; 2005 Feb; 34(1):193-7. PubMed ID: 15375086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for prostate cancer in asymptomatic men: clinical, legal, and ethical implications.
    Gerard MJ; Frank-Stromborg M
    Oncol Nurs Forum; 1998 Oct; 25(9):1561-9. PubMed ID: 9802052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing demography of prostate cancer in Asia.
    Sim HG; Cheng CW
    Eur J Cancer; 2005 Apr; 41(6):834-45. PubMed ID: 15808953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prostate cancer screening (III): risk factors, natural history, course without treatment. Characteristics of detected cancers].
    Villers A; Soulié M; Haillot O; Boccon-Gibod L
    Prog Urol; 1997 Sep; 7(4):655-61. PubMed ID: 9410329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary patterns identified using factor analysis and prostate cancer risk: a case control study in Western Australia.
    Ambrosini GL; Fritschi L; de Klerk NH; Mackerras D; Leavy J
    Ann Epidemiol; 2008 May; 18(5):364-70. PubMed ID: 18261927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer in Saudi Arabia in 2002.
    Mosli HA
    Saudi Med J; 2003 Jun; 24(6):573-81. PubMed ID: 12847583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mass screening for prostate cancer in Korea: a population based study.
    Song C; Ahn H; Lee MS; Park J; Kwon TG; Kim HJ; Choi HY;
    J Urol; 2008 Nov; 180(5):1949-52; discussion 1952-3. PubMed ID: 18801541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minority issues in prostate disease.
    French DB; Jones LA
    Med Clin North Am; 2005 Jul; 89(4):805-16. PubMed ID: 15925651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity and the risk of prostate cancer (United States).
    Bradbury BD; Wilk JB; Kaye JA
    Cancer Causes Control; 2005 Aug; 16(6):637-41. PubMed ID: 16049801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of family history on outcomes in patients treated with definitive brachytherapy for clinically localized prostate cancer.
    Peters CA; Stock RG; Blacksburg SR; Stone NN
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):24-9. PubMed ID: 18692325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Race as an independent predictor of outcome after treatment for localized prostate cancer.
    Sohayda CJ; Kupelian PA; Altsman KA; Klein EA
    J Urol; 1999 Oct; 162(4):1331-6. PubMed ID: 10492191
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence and risk factors for low trauma fractures in men with prostate cancer.
    Ahlborg HG; Nguyen ND; Center JR; Eisman JA; Nguyen TV
    Bone; 2008 Sep; 43(3):556-60. PubMed ID: 18585119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Luteinizing hormone beta polymorphism and risk of familial and sporadic prostate cancer.
    Elkins DA; Yokomizo A; Thibodeau SN; J Schaid D; Cunningham JM; Marks A; Christensen E; McDonnell SK; Slager S; J Peterson B; J Jacobsen S; R Cerhan J; L Blute M; J Tindall D; Liu W
    Prostate; 2003 Jun; 56(1):30-6. PubMed ID: 12746844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nutrition and pharmacological treatment for prevention of prostate cancer].
    Segev Y; Nativ O
    Harefuah; 2006 Jan; 145(1):47-51, 76-7. PubMed ID: 16450727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case-control study of prostate cancer].
    Du SF; Shi LY; He SP
    Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Dec; 17(6):343-5. PubMed ID: 9387599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
    Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
    J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Smoking and risk of total and fatal prostate cancer in United States health professionals.
    Giovannucci E; Rimm EB; Ascherio A; Colditz GA; Spiegelman D; Stampfer MJ; Willett WC
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):277-82. PubMed ID: 10207628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Height-related risk factors for prostate cancer.
    Norrish AE; McRae CU; Holdaway IM; Jackson RT
    Br J Cancer; 2000 Jan; 82(1):241-5. PubMed ID: 10638996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members.
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Eur Urol; 2010 Aug; 58(2):275-80. PubMed ID: 20171779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.